Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency

NCT02722304 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Alpha1-antitrypsin Deficiency

Interventions

BIOLOGICAL: ARALAST NP 60 mg/kg
BIOLOGICAL: ARALAST NP 120 mg/kg
BIOLOGICAL: GLASSIA 60 mg/kg
BIOLOGICAL: GLASSIA 120 mg/kg
BIOLOGICAL: Human Albumin 2%

Sponsor

Baxalta now part of Shire

Collaborators

[object Object]